// App-Quantinova.ai

P569 : A national, retrospective, observational study on the use of 5-aminosalicylates (5-ASA) in Crohn’s disease (CD)

Researchers

Presenter

  • A Hart

Principal Investigators

  • S C Ng

  • S Ghosh

  • J Watkins

  • J Fullarton

  • K Paridaens

Medical Centers

  • St Mark's Hospital, Harrow, London, UK

  • The Chinese University of Hong Kong, Department of Medicine & Therapeutics, Hong Kong, Hong Kong

  • University of Birmingham, Birmingham, United Kingdom

  • Public Health Wales, Cardiff, UK

  • University of Cardiff, Cardiff

  • Strategen Ltd., Basingstoke, UK

  • Ferring International Center, St-Prex, Switzerl

Locations

  • United Kingdom

  • Hong Kong

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved